ZBIO Stock Analysis: Buy, Sell, or Hold?
ZBIO - Zenas BioPharma, Inc. Common Stock
$21.86
1.50 (7.37%)
▲
5d:
-1.35%
30d:
-15.34%
90d:
-39.8%
BUY
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 21, 2026
Smart Money Accumulation
ZBIO is down 7.2% this week, but smart money is accumulating calls. Top strike: $20 2026-05-15 with 181 OI. Call ratio: 73% View Scanner →
Strength: 5.8/10
Get Alerted When ZBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ZBIO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ZBIO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ZBIO is currently trading at $21.86, which is considered oversold relative to its 30-day fair value range of $21.15 to $26.12.
Technical Outlook: Technically, ZBIO is in a strong downtrend. Immediate support is located at $17.20, while resistance sits at $24.08. The stock is showing strong short-term momentum, up 7.4% recently.
Market Sentiment: ZBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $42.00 (+106.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ZBIO is in a strong downtrend. Immediate support is located at $17.20, while resistance sits at $24.08. The stock is showing strong short-term momentum, up 7.4% recently.
Market Sentiment: ZBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $42.00 (+106.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$21.15 -
$26.12
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.4%)
- BULLISH: Trading 106.3% below Wall St target ($42.00)
Fair Price Analysis
30-Day Fair Range
$21.15 -
$26.12
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$17.20
Resistance Level
$24.08
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.17
Wall Street Target
$42.00
(+106.3%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: April 02, 2026 1:07 PM ET
Data refreshes hourly during market hours. Next update: 2:07 PM
Data refreshes hourly during market hours. Next update: 2:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZBIO showing a specific setup today?
Insider Activity (6 Months)
14
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Patricia L Allen
BUY
4160 shares
2026-02-13
Patricia L Allen
BUY
15700 shares
2026-02-12
Hongbo Lu
BUY
25985 shares
2026-02-11
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$873 | 66 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 59 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 55 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 60 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$224 | 57 HOLD |
Advanced ZBIO Option Strategies
Professional options setups generated by AI based on today's ZBIO price and gamma walls.
